Literature DB >> 20624006

Coexistence of immune thrombocytopenic purpura and idiopathic membranous glomerulonephritis successfully treated with rituximab.

Salam Alkindi1, Saif Khan, Dawood Riyami, Mahfooz Farooqi, Anil Pathare.   

Abstract

We describe here coexistence of immune thrombocytopenic purpura (ITP) and idiopathic membranous glomerularnephritis (IMG) in one individual who presented a decade ago after delivering a macerated dead fetus. Investigations performed then revealed clinical, biochemical and histopathological evidence of IMG. A year later she presented with bleeding diathesis and was diagnosed as ITP. Thereafter, she manifested with several episodes of serious bleeding complications especially in the central nervous system with considerable frequency, inspite of receiving treatment with steroids, intravenous immunoglobulin and cyclosporine. Subsequently, she received six courses of rituximab and went into complete remission. To date, after more than 3.5 years of follow up, she is completely symptom free. Co-existence of IMG and ITP has been reported earlier; however, this is the first instance of successful treatment of both these entities with rituximab.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624006     DOI: 10.3109/09537104.2010.494744

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  2 in total

Review 1.  Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review.

Authors:  Keitaro Nishizawa; Tomohisa Yamashita; Yayoi Ogawa; Hironori Kobayashi
Journal:  CEN Case Rep       Date:  2021-07-21

2.  Comprehensive identification of immune-associated biomarkers based on network and mRNA expression patterns in membranous glomerulonephritis.

Authors:  Chengwei Zhang; Lei Leng; Xiaoming Zhang; Yao Zhao; Zhaozheng Li
Journal:  J Transl Med       Date:  2018-07-24       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.